articleTop 1% cited

Mutations and prognosis in primary myelofibrosis

Leukemia · 2013 · Vol. 27(9) · pp. 1861–1869

A. M. Vannucchi✉(University of Florence)T L Lasho(Mayo Clinic)Paola Guglielmelli(University of Florence)Flavia Biamonte(University of Florence)Animesh Pardanani(Mayo Clinic)Arturo Pereira(Hospital Clínic de Barcelona)Christy M. Finke(Mayo Clinic)J Score(University of Southampton)Naseema Gangat(Mayo Clinic)C Mannarelli(University of Florence)Rhett P. Ketterling(Mayo Clinic)Giada Rotunno(University of Florence)R A Knudson(Mayo Clinic)M C Susini(University of Florence)Rebecca R. Laborde(Mayo Clinic)Ambra Spolverini(University of Florence)Alessandro Pancrazzi(University of Florence)Lisa Pieri(University of Florence)Rossella Manfredini(University of Modena and Reggio Emilia)Enrico Tagliafico(University of Modena and Reggio Emilia)Roberta Zini(University of Modena and Reggio Emilia)Amy V. Jones(University of Southampton)Katerina Zoi(Academy of Athens)Andreas Reiter(Heidelberg University)Andrew Duncombe(University Hospital Southampton NHS Foundation Trust)Daniela Pietra(Istituti di Ricovero e Cura a Carattere Scientifico)Elisa Rumi(Istituti di Ricovero e Cura a Carattere Scientifico)Francisco Cervantes(Hospital Clínic de Barcelona)Giovanni Barosi(Policlinico San Matteo Fondazione)Mario Cazzola(Istituti di Ricovero e Cura a Carattere Scientifico)Nicholas C.P. Cross(University of Southampton)Ayalew Tefferi(Mayo Clinic)

View via DOI Publisher page

Myeloproliferative Neoplasms: Diagnosis and Treatment Acute Myeloid Leukemia Research Eosinophilic Disorders and SyndromesMyelofibrosisIDH1Internal medicineCohortOncologyMedicineInternational Prognostic Scoring SystemContext (archaeology)Survival analysisMutation

MeSH terms

Serine-Arginine Splicing FactorsAdolescentAdultAgedAged, 80 and overFemaleFollow-Up StudiesHumansIsocitrate DehydrogenaseMaleMiddle AgedMutationNuclear ProteinsPrognosisRepressor Proteins